You just read:

PTC Therapeutics Announces Initial Data from Patient Registry Demonstrating Translarna™ (ataluren) Slows Disease Progression in Children with Duchenne Caused by a Nonsense Mutation

News provided by

PTC Therapeutics, Inc.

06 Oct, 2018, 12:30 BST